Omniome is a biotechnology company developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.

Register for Details

For more details on financing and valuation for Omniome, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Omniome Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/9/2020 Series C $60MM raised $XXX.XX $XXX.XX
7/30/2018 Series B-1 and B-2 $60.5MM raised $XXX.XX $XXX.XX
1/1/2016 Series A-1 and A-2 $32.79MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Omniome

Forge green plus iconForge green minus icon

What is Omniome funding to date?

Omniome has raised $153.29MM to date.
Forge green plus iconForge green minus icon

When was Omniome founded?

Omniome was founded in 2013.
Updated on: Jun 12, 2022